CTNNB1 and cancer: In addition, as somatic MLH1 and CTNNB1 mutations seem to be non-independent events [66], large deletions of the MLH1 gene prevailing in the Finnish population as a founder variant may have an impact on the routes of cancer progression and the likelihood of somatic CTNNB1 mutations [67].